Frederiksberg, Denmark

Pernille Ollendorff Micheelsen

USPTO Granted Patents = 5 

 

 

Average Co-Inventor Count = 7.0

ph-index = 2

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2019-2021

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Pernille Ollendorff Micheelsen: Innovator in Alpha-Amylase Variants

Introduction

Pernille Ollendorff Micheelsen is a notable inventor based in Frederiksberg, Denmark. She has made significant contributions to the field of biotechnology, particularly in the development of alpha-amylase variants. With a total of 5 patents to her name, Micheelsen's work has implications for various applications in industry and research.

Latest Patents

Micheelsen's latest patents focus on alpha-amylase variants and the polynucleotides encoding them. The inventions relate to the creation of these variants, as well as the nucleic acid constructs, vectors, and host cells that incorporate the polynucleotides. These innovations are crucial for advancing the understanding and utilization of alpha-amylase in various biotechnological applications.

Career Highlights

Pernille Ollendorff Micheelsen is currently employed at Novozymes A/S, a leading company in the field of enzyme production and biotechnology. Her work at Novozymes has allowed her to collaborate with other experts in the field and contribute to groundbreaking research and development.

Collaborations

Micheelsen has worked alongside talented colleagues, including Carsten Schau Andersen and Signe Eskildsen Larsen. These collaborations have fostered a dynamic environment for innovation and have led to the successful development of new biotechnological solutions.

Conclusion

Pernille Ollendorff Micheelsen is a distinguished inventor whose work on alpha-amylase variants has made a significant impact in biotechnology. Her contributions continue to influence the industry and pave the way for future innovations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…